Skip Navigation
Skip to contents




14 results

Primary Follicular Lymphoma in a Male Breast: A Case Report

Jung SP, Han KM, Kim SJ, Nam SJ, Bae JW, Lee JE

  • Cancer Res Treat.
  • 2014 Jan;46(1):104-107.
Primary breast lymphoma (PBL) is a rare disease, particularly in males. Diffuse large B cell lymphoma is the most common PBL, while follicular lymphoma is less common. Furthermore, primary follicular...
Pseudocirrhosis of Breast Cancer Metastases to the Liver Treated by Chemotherapy

Lee SL, Chang ED, Na SJ, Kim JS, An HJ, Ko YH, Won HS

  • Cancer Res Treat.
  • 2014 Jan;46(1):98-103.
Pseudocirrhosis refers to a condition that shows changes in hepatic contour that mimic cirrhosis radiographically in the absence of the typical histopathological findings of cirrhosis. This condition has been observed...
Adenoid Cystic Carcinoma of the Breast: A Case Series of Six Patients and Literature Review

Kim M, Lee DW, Im J, Suh KJ, Keam B, Moon HG, Im SA, Han W, Park IA, Noh DY

  • Cancer Res Treat.
  • 2014 Jan;46(1):93-97.
Adenoid cystic carcinoma (ACC) of the breast is a very rare and indolent tumor with a favorable prognosis, despite its triple-negative status. Due to its rarity, there has been no...
Synergistic Effect of COX-2 Inhibitor on Paclitaxel-Induced Apoptosis in the Human Ovarian Cancer Cell Line OVCAR-3

Kim HJ, Yim GW, Nam EJ, Kim YT

  • Cancer Res Treat.
  • 2014 Jan;46(1):81-92.
PURPOSE: Celecoxib, a highly selective cyclooxygenase-2 inhibitor, regulates apoptosis of several types of human cancer cells. The purpose of this study was to investigate whether celecoxib in combination with paclitaxel...
High-Dose-Rate Brachytherapy for the Treatment of Vaginal Intraepithelial Neoplasia

Song JH, Lee JH, Lee JH, Park JS, Hong SH, Jang HS, Kim YS, Choi BO, Yoon SC

  • Cancer Res Treat.
  • 2014 Jan;46(1):74-80.
PURPOSE: Vaginal intraepithelial neoplasia (VAIN), a rare premalignant condition, is difficult to eradicate. We assess the effectiveness of high-dose rate intracavitary brachytherapy (HDR-ICR) in patients with VAIN or carcinoma in...
Clinical Implications of Systemic Inflammatory Response Markers as Independent Prognostic Factors in Colorectal Cancer Patients

Paik KY, Lee IK, Lee YS, Sung NY, Kwon TS

  • Cancer Res Treat.
  • 2014 Jan;46(1):65-73.
PURPOSE: Cancer-related inflammation affects many aspects of malignancy. We confirm the effects of early postoperative systemic inflammation on cancer prognosis. MATERIALS AND METHODS: Six hundred consecutive patients underwent surgery for colorectal...
Combination of TRAP1 and ERCC1 Expression Predicts Clinical Outcomes in Metastatic Colorectal Cancer Treated with Oxaliplatin/5-Fluorouracil

Han JJ, Baek SK, Lee JJ, Kim GY, Kim SY, Lee SH

  • Cancer Res Treat.
  • 2014 Jan;46(1):55-64.
PURPOSE: The novel heat shock protein tumor necrosis factor receptor-associated protein 1 (TRAP1) is associated with multidrug resistance in colorectal cancer (CRC) cells in vitro. Excision repair cross-complementation group 1...
Dose KRAS Mutation Status Affect on the Effect of VEGF Therapy in Metastatic Colon Cancer Patients?

Kim ST, Park KH, Shin SW, Kim YH

  • Cancer Res Treat.
  • 2014 Jan;46(1):48-54.
PURPOSE: Mutations affecting the KRAS gene are an established negative predictor for anti-epidermal growth factor receptor (anti-EGFR) therapies in metastatic colorectal cancer (CRC). However, the role of KRAS mutation as...
A Distribution Weighted Prognostic Scoring Model for Node Status in Advanced Rectal Cancer

Yeo KH, Kim HH, Kim DY, Kim YJ, Ju JK

  • Cancer Res Treat.
  • 2014 Jan;46(1):41-47.
PURPOSE: There are various lymph node-based staging systems. Nevertheless, there is debate over the use of parameters such as the number of involved lymph nodes and the lymph node ratio....
The Role of Radiotherapy in the Treatment of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

Nam TK, Ahn JS, Choi YD, Jeong JU, Kim YH, Yoon MS, Song JY, Ahn SJ, Chung WK

  • Cancer Res Treat.
  • 2014 Jan;46(1):33-40.
PURPOSE: To assess radiotherapy for patients with early stage gastric mucosa-associated lymphoid tissue (MALT) lymphoma with respect to survival, treatment response, and complications. MATERIALS AND METHODS: Enrolled into this study were...
Chemotherapy in Advanced Gastric Cancer Patients Associated with Disseminated Intravascular Coagulation

Hwang IG, Choi JH, Park SH, Oh SY, Kwon HC, Lee SI, Lim DH, Lee GW, Kang JH

  • Cancer Res Treat.
  • 2014 Jan;46(1):27-32.
PURPOSE: Little is known about the clinical features of advanced gastric cancer (AGC) combined with disseminated intravascular coagulation (DIC). The main objective of this study was to determine the clinical...
A Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy

Lee HY, Kim HK, Lee KH, Kim BS, Song HS, Yang SH, Kim JH, Kim YH, Kim JG, Kim SW, Kim DW, Kim SY, Park HS

  • Cancer Res Treat.
  • 2014 Jan;46(1):19-26.
PURPOSE: This study was conducted to evaluate the efficacy and safety of azasetron compared to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting. MATERIALS AND METHODS: This study was...
Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice

Prasad S, Tyagi AK, Aggarwal B

  • Cancer Res Treat.
  • 2014 Jan;46(1):2-18.
Curcumin (diferuloylmethane) is a yellow pigment present in the spice turmeric (Curcuma longa) that has been associated with antioxidant, anti-inflammatory, anticancer, antiviral, and antibacterial activities as indicated by over 6,000...
Editorial: New Systems Introduced for the Betterment of Our Journal

Kim IH

  • Cancer Res Treat.
  • 2014 Jan;46(1):1-1.
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: